Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus.

Ekmekci A, Cicek G, Uluganyan M, Gungor B, Osman F, Ozcan KS, Bozbay M, Ertas G, Zencirci A, Sayar N, Eren M.

Angiology. 2014 Feb;65(2):154-9. doi: 10.1177/0003319713488930. Epub 2013 May 8.

PMID:
23657174
2.
3.
4.

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.

Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, Dambrink JH, Bilo HJ, Zijlstra F, van 't Hof AW.

Circulation. 2011 Aug 9;124(6):704-11. doi: 10.1161/CIRCULATIONAHA.110.985911. Epub 2011 Jul 18.

5.

The relationship between γ-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Gul M, Uyarel H, Ergelen M, Ekmekci A, Ozal E, Murat A, Kul S, Celik O, Karaca G, Akturk F, Eksik A.

Coron Artery Dis. 2013 Jun;24(4):272-8. doi: 10.1097/MCA.0b013e328360d131.

PMID:
23542158
6.

What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?

Tomaszuk Kazberuk A, Kożuch M, Małyszko J, Bachórzewska Gajewska H, Dobrzycki S, Kosacka U, Musiał WJ.

Kardiol Pol. 2012;70(6):564-72. English, Polish.

7.

Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.

Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L.

Kardiol Pol. 2013;71(3):260-7. doi: 10.5603/KP.2013.0038.

8.

Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.

Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H; Japanese Acute Coronary Syndrome Study Investigators.

Am Heart J. 2005 Oct;150(4):814-20.

PMID:
16209987
9.

Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Seo SM, Kim S, Chang K, Min J, Kim TH, Koh YS, Park HJ, Shin WS, Lee JM, Kim PJ, Chung WS, Seung KB.

Coron Artery Dis. 2011;22(6):405-10. doi: 10.1097/MCA.0b013e3283487dac.

PMID:
21701385
10.

Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.

Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM.

Am J Cardiol. 2012 Sep 1;110(5):621-7. doi: 10.1016/j.amjcard.2012.04.041. Epub 2012 May 18.

PMID:
22608360
11.

Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.

Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, Isik T, Cicek G, Elcik D, Sahin O, Cosgun SM, Oguzhan A, Eren M, Gibson CM.

Am J Cardiol. 2012 Feb 15;109(4):486-91. doi: 10.1016/j.amjcard.2011.09.042. Epub 2011 Nov 17.

PMID:
22100027
12.

Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.

Planer D, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Xu K, Fahy M, Mehran R, Stone GW.

Int J Cardiol. 2013 Sep 10;167(6):2572-9. doi: 10.1016/j.ijcard.2012.06.054. Epub 2012 Jul 12.

PMID:
22795245
13.
14.

Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.

Gasior M, Stasik-Pres G, Pres D, Lech P, Gierlotka M, Lekston A, Hawranek M, Tajstra M, Kalarus Z, Poloński L.

Kardiol Pol. 2007 Sep;65(9):1031-8; discussion 1039-40.

15.

Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Hoebers LP, Damman P, Claessen BE, Vis MM, Baan J Jr, van Straalen JP, Fischer J, Koch KT, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP.

Am J Cardiol. 2012 Jan 1;109(1):53-9. doi: 10.1016/j.amjcard.2011.07.067. Epub 2011 Sep 23.

PMID:
21944676
16.

In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.

Vis MM, Sjauw KD, van der Schaaf RJ, Baan J Jr, Koch KT, DeVries JH, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP.

Am Heart J. 2007 Dec;154(6):1184-90. Epub 2007 Sep 12.

PMID:
18035093
17.

Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction.

Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, Müller-Bardorff M, Richardt G, Katus HA.

Crit Care Med. 2002 Oct;30(10):2229-35.

PMID:
12394949
19.

Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study.

Tian L, Zhu J, Liu L, Liang Y, Li J, Yang Y.

Coron Artery Dis. 2013 Jan;24(1):16-22. doi: 10.1097/MCA.0b013e32835b3971.

PMID:
23168569
20.

Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.

Ege M, Güray U, Güray Y, Yılmaz MB, Demirkan B, Saşmaz A, Korkmaz S.

Anadolu Kardiyol Derg. 2011 May;11(3):213-7. doi: 10.5152/akd.2011.055. Epub 2011 Mar 21.

Supplemental Content

Support Center